The Center for Biosimilars’ Samantha DiGrande notes that the Institute for Clinical and Economic Review (ICER) released a Final Condition Update report and a Report-at-a-Glance on immunomodulators for the treatment of moderate to severe plaque psoriasis. The updated...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
